Related Experiment Video
Updated: Jul 3, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
S10 phosphorylation of p27 mediates atRA induced growth arrest in ovarian carcinoma cell lines
Maria Radu1, Dianne R Soprano, Kenneth J Soprano
1Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Abstract:
All trans retinoic acid (atRA) has been shown to inhibit the growth of CAOV3 ovarian carcinoma cells and to elevate the level of p27 cyclin-dependent kinase inhibitor. We report here that phosphorylation at S10 residue is an important event in mediating p27 role in atRA induced growth arrest. atRA treatment of atRA sensitive CAOV3 cells increases the levels of S10 phospho-p27 in both nuclear and cytoplasmic cell compartments. This increase is accompanied by a decrease in the levels of skp2 protein. This effect was not observed in SKOV3 cells which are resistant to atRA growth inhibitory effect. An A10-p27 mutant that cannot be phosphorylated at S10 induces a dominant negative effect on the atRA effect on the levels and activity of endogenous p27. Overexpression of A10-p27 mutant renders CAOV3 cells more resistant to atRA treatment and reverses the effect that atRA has on p27 binding to CDKs, on CDK activity, and on the expression of S phase genes.
Insights
All trans retinoic acid (atRA) inhibits ovarian cancer cell growth by increasing p27 protein phosphorylation. This specific modification is crucial for atRA
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- All trans retinoic acid (atRA) is known to inhibit ovarian carcinoma cell growth.
- p27 is a cyclin-dependent kinase inhibitor whose levels are elevated by atRA.
Purpose of the Study:
- To investigate the role of p27 phosphorylation at the S10 residue in mediating atRA-induced growth arrest in ovarian cancer cells.
- To compare the effects of atRA on sensitive (CAOV3) versus resistant (SKOV3) cell lines.
Main Methods:
- Treatment of CAOV3 and SKOV3 cells with atRA.
- Analysis of p27, phospho-p27 (S10), and skp2 protein levels.
- Use of an S10-non-phosphorylatable p27 mutant (A10-p27) to assess dominant-negative effects.
Main Results:
- atRA treatment increased S10 phospho-p27 levels in CAOV3 cells, accompanied by decreased skp2 levels.
- Resistant SKOV3 cells did not show these changes.
- The A10-p27 mutant impaired atRA's effects on p27/CDK interactions, CDK activity, and S-phase gene expression, conferring resistance.
Conclusions:
- Phosphorylation of p27 at S10 is a critical mechanism for all trans retinoic acid-induced growth arrest in ovarian cancer.
- Targeting p27 phosphorylation could be a strategy to overcome resistance to atRA in ovarian carcinoma.
Related Concept Videos
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
